Hester Biosciences submits analyst meet outcome

05 Aug 2024 Evaluate
Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has attached the transcript of the earnings conference call held by the management of the Company with investors on Friday, 2 August 2024 at 2:00 pm (IST) to discuss the financial results for the for the quarter ended 30 June 2024.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1541.25 -12.40 (-0.80%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×